Exchange: NYSE·Updated 07:40 PM EDT

HTGC News

News
all
press releases
Hercules Capital (HTGC) Advances While Market Declines: Some Information for Investors
In the most recent trading session, Hercules Capital (HTGC) closed at $16.55, indicating a +1.16% shift from the previous trading day.
Zacks
Hercules Capital (HTGC) Advances While Market Declines: Some Information for Investors
In the most recent trading session, Hercules Capital (HTGC) closed at $16.55, indicating a +1.16% shift from the previous trading day.
Zacks
More News
Hercules Capital Closes Institutional Notes Offering of $400.0 Million 6.700% Notes due 2029
Hercules Capital, Inc. (NYSE: HTGC) (Hercules, Hercules Capital, or the Company), today announced that it has closed an upsized underwritten public offering of $400.0 million in aggregate principal amount of 6.700% notes due October 2029 (the Notes). The Notes are unsecured and bear interest at a...
Business Wire
Wall Street's Most Accurate Analysts Give Their Take On 3 Financial Stocks With Over 10% Dividend Yields
Trinity Capital, Blue Owl Capital and Hercules Capital offer 10%+ dividend yields, with mixed analyst ratings and updated price targets.read more...
Benzinga
Rocket Pharmaceuticals Secures Strategic Credit Facility for Up to $150 Million from Hercules Capital
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, commercial-stage biotechnology company advancing genetic medicines for rare and life-threatening diseases, focused on inherited cardiovascular disorders, today announced that it has entered into a credit facility agreement with...
Business Wire
Hercules Capital Prices Upsized Institutional Notes Offering of $400.0 Million 6.70% Notes due 2029
Hercules Capital, Inc. (NYSE: HTGC) (Hercules, Hercules Capital, or the Company), today announced that it has priced an underwritten public offering of $400.0 million in aggregate principal amount of 6.70% notes due October 2029 (the Notes). The closing of the transaction is subject to customary...
Business Wire
Hercules Capital (HTGC) Stock Sinks As Market Gains: Here's Why
Hercules Capital (HTGC) closed at $16.74 in the latest trading session, marking a -1.18% move from the prior day.
Zacks
NorthStar Secures Up to $185 Million Growth Financing Led by Hercules Capital to Scale Actinium-225 Production and Radiopharmaceutical Manufacturing for Next-Generation Precision Cancer Therapies
NorthStar Medical Technologies, LLC (NorthStar), the first commercial-scale producer of no-carrier-added actinium-225 (n.c.a. Ac-225) using electron-accelerator technology, today announced a multi-year growth capital facility of up to $185 million with Hercules Capital, Inc. (NYSE: HTGC) to support...
Business Wire
Is It Worth Investing in Hercules Capital (HTGC) Based on Wall Street's Bullish Views?
Based on the average brokerage recommendation (ABR), Hercules Capital (HTGC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Zacks
Hercules Capital (HTGC) Dips More Than Broader Market: What You Should Know
Hercules Capital (HTGC) closed the most recent trading day at $16.8, moving 1% from the previous trading session.
Zacks
Here's Why Hercules Capital (HTGC) Fell More Than Broader Market
Hercules Capital (HTGC) closed at $16.97 in the latest trading session, marking a -1.45% move from the prior day.
Zacks

Advertisement|Remove ads.